Compare Deckers Outdoor Corp (DECK) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deckers Outdoor Corp vs TransMedics Group Inc — how do they compare? Deckers Outdoor Corp trades at $82.89 (market cap $11.24B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: Deckers Outdoor Corp is far larger — about 4.1× TransMedics Group Inc's market cap, and TransMedics Group Inc is more actively traded (949,331 versus 3,010,945). Which is the better fit depends on your goals — on Pluang, investors hold Deckers Outdoor Corp for 71 Days and TransMedics Group Inc for 24 Days on average.
| DECK | TMDX | |
|---|---|---|
Market Cap | $11.24B | $2.74B |
Volume | 3,010,945 | 949,331 |
Sector | Consumer Cyclical | Health |
52-Week High | $120.94 | $150.42 |
52-Week Low | $77.51 | $61.99 |
Typical Hold Time | 71 Days | 24 Days |
Enterprise Value | $10.11B | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DECK trades at $82.56, up 2.71% today, with a bullish technical signal and strong fundamentals. Recent earnings beats and robust brand momentum from HOKA and UGG support growth. The stock shows high profitability with a net margin of 18.36% and ROE of 42.56%. Valuation ratios like P/E of 11.74 appear attractive relative to earnings power. Support is firm near $81, with resistance at $83.
Outlook remains positive given consistent earnings outperformance and analyst consensus price target of $117.13, implying significant upside. Risks include reliance on key brands and competitive pressures. Institutional interest is strong, but investors should monitor execution on fiscal 2027 growth targets amid economic uncertainties.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deckers Outdoor Corp
Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.
Read more on DECK →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
